ProofPilot Bolsters Advisory Board With Appointment of Michelle Everill
ProofPilot Bolsters Advisory Board With Appointment of Michelle Everill
NEW YORK, Sept. 3, 2024 /PRNewswire/ -- ProofPilot, the leading Clinical Experience Platform (CXP) that centralizes and simplifies communication for sponsors, patients, and sites across the clinical trial experience, welcomes the addition of Michelle Everill, VP, Global Trial Optimization at Alnylam Pharmaceuticals, and CEO of Michelle Everill Coaching LLC, to its Strategic Advisory Board.
ProofPilot，全球臨床試驗體驗平台（CXP）的領導者，通過集中和簡化贊助商、患者和研究場地之間的溝通，改善和簡化臨床試驗體驗，在其戰略諮詢委員會中歡迎輝瑞全球試驗優化VP Michelle Everill和Michelle Everill Coaching LLC的首席執行官Michelle Everill的加入。
Michelle has over 20 years of diverse experience spanning across data analytics, clinical operations, patient recruitment and feasibility strategy. She has held leadership roles at Bristol Myers Squibb, Johnson & Johnson Innovative Medicine, Pfizer and PPD.
Michelle擁有超過20年的多樣化經驗，涵蓋數據分析、臨床運營、患者招募和可行性策略。她曾在百時美施貴寶、強生創新藥、輝瑞和PPD擔任領導職務。
"Michelle adds a tremendous amount of knowledge and fresh perspectives to our team," said Chris Venezia, CEO of ProofPilot. "Her impressive track record in enhancing clinical trial performance and driving significant cost savings will be invaluable as we continue to push the boundaries of what's possible in our industry."
ProofPilot首席執行官Chris Venezia表示:"Michelle向我們的團隊帶來了大量的知識和新觀點。她在提高臨床試驗績效和實現顯著成本節約方面的卓越業績將是我們在行業中不斷突破可能性的寶貴財富。"
As a member of the Strategic Advisory Board, Michelle will provide invaluable guidance on product direction and strategic initiatives to improve the patient, site, and study team experience in clinical trials.
作爲戰略諮詢委員會的成員，Michelle將就產品方向和戰略舉措提供寶貴的指導，以改善臨床試驗中患者、研究場地和研究團隊的體驗。
"Joining ProofPilot's Strategic Advisory Board is an exciting opportunity to work with a forward-thinking team dedicated to modernizing clinical trials," said Michelle Everill, VP, Global Trial Optimization at Alnylam Pharmaceuticals, and CEO of Michelle Everill Coaching LLC. "I am eager to contribute my expertise to initiatives that will drive impactful advancements in clinical research, leveraging innovative strategies to improve trial outcomes and patient experiences."
"加入ProofPilot的戰略諮詢委員會是一個令人興奮的機會，與一個致力於現代化臨床試驗的前瞻性團隊合作。" Michelle Everill輝瑞全球試驗優化副總裁兼Michelle Everill Coaching LLC首席執行官說:"我渴望爲推動臨床研究取得有重大影響的進展做出貢獻，藉助創新策略來改善試驗結果和患者體驗。"
ProofPilot will continue to announce new members of its Strategic Advisory Board, ensuring its solutions deliver immediate and long-term value for all stakeholders.
ProofPilot將繼續宣佈其戰略諮詢委員會的新成員，確保其解決方案爲所有利益相關者提供即時和長期價值。
About ProofPilot
關於ProofPilot
ProofPilot enhances clinical trials with its Clinical Experience Platform. The StudyCoPilot platform centralizes and simplifies communication for sponsors, patients, and sites across the clinical trial experience. Learn more at: .
ProofPilot通過其臨床體驗平台增強臨床試驗。StudyCoPilot平台集中和簡化了贊助商、患者和研究場地之間的溝通，在整個臨床試驗體驗中提供支持。了解更多信息：。
Media Contact: Colleen yang, [email protected]
媒體聯繫人：Colleen yang，[email protected]
SOURCE ProofPilot
來源：ProofPilot
譯文內容由第三人軟體翻譯。